Doug Brunk

Doug Brunk is a San Diego-based award-winning reporter who began covering health care in 1991. Before joining the company, he wrote for the health sciences division of Columbia University and was an associate editor at Contemporary Long Term Care magazine when it won a Jesse H. Neal Award. His work has been syndicated by the Los Angeles Times and he is the author of two books related to the University of Kentucky Wildcats men's basketball program. Doug has a master’s degree in magazine journalism from the S.I. Newhouse School of Public Communications at Syracuse University. Follow him on Twitter @dougbrunk.

News

Pruritus in elderly patients: Not a diagnosis

Author:: Doug Brunk

Publish date: January 26, 2022

“That’s just a symptom with a million etiologies,” Dr. Eric L. Simpson said.

News

More frequent secukinumab dosing found to benefit overweight psoriasis patients

Author:: Doug Brunk

Publish date: January 26, 2022

“The need for individualized treatment in psoriasis is very real,” Dr. Raj Chovatiya said.

News

Phase 2 studies of novel JAK1 inhibitor for HS show promise

Author:: Doug Brunk

Publish date: January 21, 2022

Specifically targeting JAK1 may reduce cytokine signaling involved in HS pathogenesis while limiting JAK2-mediated cytopenias.

News

FDA approves two JAK-1 inhibitors for moderate to severe atopic dermatitis

Author:: Doug Brunk

Publish date: January 14, 2022

“It’s big news because a few years ago we didn’t have any systemic treatments that are safer than the classical immunosuppressants.”

News

Hand eczema and atopic dermatitis closely linked

Author:: Doug Brunk

Publish date: January 14, 2022

“As clinicians, we sometimes need to rule out a few differentials, including psoriasis and T-cell lymphoma,” Dr. Jacob P. Thyssen said.

News

Sorting out sleep complaints in children with AD can be complex

Author:: Doug Brunk

Publish date: January 12, 2022

“There’s a loss of about 50 minutes of sleep per night in children with AD,” Dr. Stephen H. Sheldon said.

News

Key questions to ask atopic dermatitis patients with sleep complaints

Author:: Doug Brunk

Publish date: January 7, 2022

Assessment tools to consider are the Epworth Sleepiness Scale, the Insomnia Severity Index, and the STOP-Bang questionnaire.

News

Longitudinal course of atopic dermatitis often overlooked, expert says

Author:: Doug Brunk

Publish date: January 6, 2022

“Understanding the long-term course may improve our ability to phenotype, prognosticate, and personalize our care,” Dr. Raj Chovatiya said.

News

Itch-dominant atopic dermatitis often flies under the radar

Author:: Doug Brunk

Publish date: January 5, 2022

A disconnect often exists between clinician-reported and patient-reported outcome measures, says Dr. Jonathan Silverberg.

News

Atopic dermatitis can be especially burdensome in the elderly

Author:: Doug Brunk

Publish date: January 4, 2022

There is good data on higher relative risk of osteoporosis/fractures and dementia specifically among older adults with AD.

News

FDA gives nod to tralokinumab for adults with moderate to severe AD

Author:: Doug Brunk

Publish date: December 28, 2021

The drug is expected to be available by February 2022.

News

Does atopic dermatitis pose an increased risk of acquiring COVID-19?

Author:: Doug Brunk

Publish date: December 28, 2021

“If you have more severe respiratory disease, the advice to dermatologists is to consult with an infectious medic...

News

AD burden may be greater for those with head, neck, face, and hand involvement

Author:: Doug Brunk

Publish date: December 23, 2021

“These findings highlight the importance of detailed assessment of specific areas affected by AD to personalize treatment approaches to the needs o...